AQUIPTA 60 mg, Tabletten

7680691280030 CH-69128 Tabletten

Associated product:

AQUIPTA cpr 60 mg 28 pce
AQUIPTA 60 mg, Tabletten
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/07/2025
Patient information leaflet
Français
29/07/2025
Patient information leaflet
Italien
29/07/2025
Summary of Product Characteristics
Allemand
29/07/2025
Summary of Product Characteristics
Français
29/07/2025
Summary of Product Characteristics
Italien
29/07/2025

Detailed composition

Substance Quantity Type Category
atogepantum
60.0 MG Substance Wirkstoff (Principe actif)
copovidonum
- Substance HNIDK
tocofersolanum
- Substance HNIDK
mannitolum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrium
31.48 MG Substance HBESI

Reimbursement information

Public price
CHF 360.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2024

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
69128
Drug name
AQUIPTA, Tabletten
Galenic form
TAB
ATC Code
N02CD07
Authorization status
Z
Dispensing category
B
First authorization
06/03/2024
Authorization expiration date
05/03/2029
IT Number
02.05.1.
Domain
Human medicine
Field of application
Migräneprophylaxe bei Erwachsenen

Package details

Description (FR)
AQUIPTA cpr 60 mg 28 pce
Description (DE)
AQUIPTA Tabl 60 mg 28 Stk
Market launch
06/03/2024
Narcotic (BTM)
No

Other package sizes (1)

AQUIPTA cpr 10 mg 28 pce
28 TABL
GTIN: 7680691280016
View
Buy us a coffee Explore the data